You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Casper Pharma Llc Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for CASPER PHARMA LLC, and what generic and branded alternatives to CASPER PHARMA LLC drugs are available?

CASPER PHARMA LLC has fifteen approved drugs.

Summary for Casper Pharma Llc

US Patents:	0
Tradenames:	16
Ingredients:	15
NDAs:	15

Drugs and US Patents for Casper Pharma Llc

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Casper Pharma Llc	FURADANTIN	nitrofurantoin	SUSPENSION;ORAL	009175-002	Jun 9, 2023		RX	Yes	Yes		⤷ Sign Up				⤷ Sign Up
Casper Pharma Llc	FURADANTIN	nitrofurantoin	SUSPENSION;ORAL	009175-001	Approved Prior to Jan 1, 1982	AB	RX	Yes	No		⤷ Sign Up				⤷ Sign Up
Casper Pharma Llc	LUMI-SPORYN	bacitracin zinc; neomycin sulfate; polymyxin b sulfate	OINTMENT;OPHTHALMIC	050417-001	Approved Prior to Jan 1, 1982	AT	RX	Yes	No		⤷ Sign Up				⤷ Sign Up
Casper Pharma Llc	CASPORYN HC	hydrocortisone; neomycin sulfate; polymyxin b sulfate	SUSPENSION/DROPS;OTIC	060613-001	Approved Prior to Jan 1, 1982	AT	RX	Yes	Yes		⤷ Sign Up				⤷ Sign Up
Casper Pharma Llc	EDETATE CALCIUM DISODIUM	edetate calcium disodium	INJECTABLE;INJECTION	216435-001	May 3, 2023		RX	No	Yes		⤷ Sign Up				⤷ Sign Up
Casper Pharma Llc	THALITONE	chlorthalidone	TABLET;ORAL	019574-001	Dec 20, 1988		RX	Yes	No		⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Casper Pharma Llc

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Casper Pharma Llc	ROBINUL	glycopyrrolate	TABLET;ORAL	012827-001	Approved Prior to Jan 1, 1982	7,091,236	⤷ Sign Up
Casper Pharma Llc	ZYLOPRIM	allopurinol	TABLET;ORAL	016084-001	Approved Prior to Jan 1, 1982	3,624,205	⤷ Sign Up
Casper Pharma Llc	ZYLOPRIM	allopurinol	TABLET;ORAL	016084-002	Approved Prior to Jan 1, 1982	3,624,205	⤷ Sign Up
Casper Pharma Llc	THALITONE	chlorthalidone	TABLET;ORAL	019574-001	Dec 20, 1988	4,933,360	⤷ Sign Up
Casper Pharma Llc	ROBINUL FORTE	glycopyrrolate	TABLET;ORAL	012827-002	Approved Prior to Jan 1, 1982	7,091,236	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Paragraph IV (Patent) Challenges for CASPER PHARMA LLC drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Tablets	1 mg	➤ Subscribe	2009-08-14
➤ Subscribe	Tablets	2 mg	➤ Subscribe	2010-10-12
➤ Subscribe	Tablets	1.5 mg	➤ Subscribe	2009-05-06

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Casper Pharma Llc

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.